# Pharmacokinetics (PK) and Safety Study of XARTEMIS® XR in Postsurgical Adolescent Subjects With Moderate to Severe Acute Pain

> **NCT02508935** · PHASE4 · TERMINATED · sponsor: **Mallinckrodt** · enrollment: 23 (actual)

## Conditions studied

- Acute Pain

## Interventions

- **DRUG:** XARTEMIS XR

## Key facts

- **NCT ID:** NCT02508935
- **Lead sponsor:** Mallinckrodt
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-11-20
- **Primary completion:** 2017-04-26
- **Final completion:** 2017-04-26
- **Target enrollment:** 23 (ACTUAL)
- **Why stopped:** Business decision
- **Last updated:** 2020-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02508935

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02508935, "Pharmacokinetics (PK) and Safety Study of XARTEMIS® XR in Postsurgical Adolescent Subjects With Moderate to Severe Acute Pain". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02508935. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*